A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC) Meeting Abstract
| Authors: | Traina, T. A.; Hudis, C.; Lehman, R.; Rege, J.; Wang, W.; Cox, D.; Seidman, A. D. |
| Abstract Title: | A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC) |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009801052 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.TPS1145 |
| Notes: | Meeting Abstract: TPS1145 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
